Diabetes Mellitus, Type 1: all 3,614 studies

Page 10 of 37. Open to participants first (585), then studies with results posted, then the rest; newest registration first within each.

• Empa Add on to Insulin in Japanese Patient With Type 1 Diabetes MellitusCompletedNCT02702011Phase 2Results posted
• The iLet Introduction Study: A Feasibility Study of the iLet, a Fully Integrated Bihormonal Bionic PancreasTerminatedNCT02701257Not applicableResults posted
• Intra-nasal Naloxone for Treatment of Impaired Awareness of HypoglycemiaTerminatedNCT02700048Phase 1/2Results posted
• Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)CompletedNCT02691247Phase 2Results posted
• A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes MellitusCompletedNCT02688933Phase 4Results posted
• Exercise Detection StudyCompletedNCT02688218Not applicableResults posted
• Additional Insulin for Fat and Protein in Children With Diabetes StudyTerminatedNCT02680054Phase 4Results posted
• Project Nightlight: Efficacy and System Acceptance of Dinner/Night vs. 24hr Closed Loop ControlCompletedNCT02679287Not applicableResults posted
• Effect of Canagliflozin in T1DM (Type 1 Diabetes Melitus) After Interruption of Continuous Subcutaneous Insulin InfusionCompletedNCT02673138Not applicableResults posted
• Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 DiabetesCompletedNCT02670915Phase 3Results posted
• Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus (T1DM) PatientsCompletedNCT02666430Phase 3Results posted
• Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 DiabetesCompletedNCT02660827Not applicableResults posted
• The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 DiabetesCompletedNCT02660242Phase 2Results posted
• Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 DiabeticsCompletedNCT02656069Phase 3Results posted
• Qingdao: Insulin Pump Follow-Up ProgramTerminatedNCT02655666Results posted
• Modulation of STAT3 Signaling With Siltuximab in Type 1 DiabetesCompletedNCT02641522Early Phase 1Results posted
• Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN StudyCompletedNCT02632747Phase 2Results posted
• A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 DiabetesCompletedNCT02624804Phase 1Results posted
• Continuos Subcutaneous Insulin Infusion in ItalyCompletedNCT02620917Results posted
• Artificial Pancreas in Pediatric Patients (PEDarPAN)CompletedNCT02620878Not applicableResults posted
• Standardized Evaluation of Subcutaneous Glucose Monitoring Systems Under Routine Environmental ConditionsCompletedNCT02614768Not applicableResults posted
• Accu-Chek® CONNECT at School (CATS) Pediatric StudyCompletedNCT02609633Not applicableResults posted
• ACCU-CHEK Connect Personal Diabetes Management Study (PDM CONNECT)CompletedNCT02600845Not applicableResults posted
• The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DMCompletedNCT02582840Phase 1Results posted
• The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DMCompletedNCT02582814Phase 3Results posted
• Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes Mellitus (TN20)CompletedNCT02580877Phase 2Results posted
• Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3)CompletedNCT02580591Phase 3Results posted
• Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DMCompletedNCT02558491Not applicableResults posted
• Pilot Prospective CGM Quality Improvement (QI) Project in PregnancyCompletedNCT02556554Not applicableResults posted
• Bromocriptine Quick Release (BCQR) as Adjunct Therapy in Type 1 DiabetesCompletedNCT02544321Phase 2Results posted
• A Euglycemic Insulin Clamp Study in Type 1 Diabetic Patients With Oral Insulin (ORAMED)CompletedNCT02535715Phase 2Results posted
• A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy AloneCompletedNCT02531035Phase 3Results posted
• Continuous Glucose Monitor in Children With Poorly Controlled DiabetesCompletedNCT02530450Results posted
• Afrezza Safety and Pharmacokinetics Study in Pediatric PatientsCompletedNCT02527265Phase 2Results posted
• Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 DiabetesCompletedNCT02518945Phase 3Results posted
• Liraglutide in Adolescents With Type 1 DiabetesCompletedNCT02516657Phase 3Results posted
• Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of GlucagonCompletedNCT02516150Phase 4Results posted
• Diabetes Strengths Study - Pilot of Provider-delivered Strengths-based InterventionCompletedNCT02510664Not applicableResults posted
• Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 DiabetesCompletedNCT02502071Phase 4Results posted
• Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes MellitusCompletedNCT02500979Phase 1Results posted
• Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 DiabetesCompletedNCT02500706Phase 3Results posted
• Shared Medical Decision Making in Pediatric DiabetesCompletedNCT02496156Not applicableResults posted
• Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal TransplantCompletedNCT02464878Phase 2Results posted
• EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 DiabetesCompletedNCT02464033Phase 2Results posted
• Hybrid Closed Loop Pivotal Trial in Type 1 DiabetesCompletedNCT02463097Not applicableResults posted
• Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 DiabetesCompletedNCT02460978Phase 3Results posted
• Dose-ranging Study in Patients With Type 1 Diabetes MellitusCompletedNCT02459899Phase 2Results posted
• A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell FunctionCompletedNCT02443155Phase 2Results posted
• Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive AlgorithmsCompletedNCT02438189Not applicableResults posted
• Education Effectiveness for Type 1 Diabetes Mellitus on Insulin Pump TherapyCompletedNCT02423993Not applicableResults posted
• Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin TherapyCompletedNCT02421510Phase 3Results posted
• Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)CompletedNCT02414958Phase 3Results posted
• Mini-Dose Glucagon to Treat Non-Severe HypoglycemiaCompletedNCT02411578Phase 2Results posted
• Clinical Assessment of a Closed-loop System With Glucagon, Exercise and Mixed MealsCompletedNCT02397265Not applicableResults posted
• Prevention Trial: Immune-tolerance With Alum-GAD (Diamyd) and Vitamin D3 to Children With Multiple Islet AutoantibodiesTerminatedNCT02387164Phase 2Results posted
• Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin TherapyCompletedNCT02384941Phase 3Results posted
• Efficacy and Safety of Sotagliflozin in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1CCompletedNCT02383940Phase 2Results posted
• Verapamil for Beta Cell Survival Therapy in Type 1 DiabetesCompletedNCT02372253Phase 2Results posted
• Assessment of an Automatic Closed-loop Insulin Delivery SystemCompletedNCT02366767Not applicableResults posted
• GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1)CompletedNCT02352974Phase 1Results posted
• Randomized Trial Comparing Sitagliptin to Placebo in Closed LoopCompletedNCT02328040Phase 1Results posted
• USS Virginia Closed-Loop Versus SAP Therapy for Hypoglycemia Reduction in T1DCompletedNCT02302963Not applicableResults posted
• Tocilizumab (TCZ) in New-onset Type 1 DiabetesCompletedNCT02293837Phase 2Results posted
• Albiglutide Versus Placebo in Insulin-treated Subjects With New-onset Type 1 Diabetes MellitusCompletedNCT02284009Phase 2Results posted
• Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring SystemsCompletedNCT02283411Not applicableResults posted
• Hybrid Closed-Loop Hotel Studies With Medtronic PID ControllerCompletedNCT02280863Not applicableResults posted
• Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin GlargineCompletedNCT02273180Phase 3Results posted
• Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 DiabetesCompletedNCT02268214Phase 3Results posted
• A Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Type 1 DiabetesCompletedNCT02258373Not applicableResults posted
• Adult Accuracy Study of the Enlite 3 Glucose SensorCompletedNCT02246582Not applicableResults posted
• Three-way, Cross-over Closed-loop Exercise StudyCompletedNCT02241889Not applicableResults posted
• A Safety, Tolerability, and Efficacy Study of VC-01™ Combination Product in Subjects With Type I Diabetes MellitusTerminatedNCT02239354Phase 1/2Results posted
• Evaluation of 18 F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell MassCompletedNCT02236754Early Phase 1Results posted
• An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT)CompletedNCT02232698Not applicableResults posted
• Non-inferiority Study to Compare the Efficacy and Safety of Mylan's Insulin Glargine With Lantus® in Type 1 Diabetes Mellitus Patients (INSTRIDE 1)CompletedNCT02227862Phase 3Results posted
• Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 DiabetesCompletedNCT02218619Phase 2Results posted
• Arterial Stiffness in Type I Diabetes MellitusCompletedNCT02218268Results posted
• ATG-GCSF in New Onset Type 1 DiabetesCompletedNCT02215200Phase 2Results posted
• Allogeneic Islet Cells Transplanted Onto the OmentumCompletedNCT02213003Phase 1/2Results posted
• A Randomized Double Blinded Study to Examine the Use of N-acetyl Cysteine for the Prevention and Treatment of HAAF in Patients With Type 1 DiabetesCompletedNCT02206152Phase 1/2Results posted
• Hyaluronidase Effect on Infusion Set LifeCompletedNCT02199028Phase 1Results posted
• A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin RequirementsCompletedNCT02152384Phase 1Results posted
• Physical Activity in Children With Type 1 Diabetes StudyCompletedNCT02144337Not applicableResults posted
• A Study of Effects of Canagliflozin as Add-on Therapy to Insulin in the Treatment of Participants With Type 1 Diabetes Mellitus (T1DM)CompletedNCT02139943Phase 2Results posted
• Pilot Study 3 of Outpatient Control-to-Range: Safety and Efficacy With Day-and-Night In-Home UseCompletedNCT02137512Not applicableResults posted
• In Clinic Evaluation of the PLGM FeatureCompletedNCT02130284Not applicableResults posted
• Threshold Suspend in Pediatrics at HomeCompletedNCT02120794Not applicableResults posted
• A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat TissueCompletedNCT02109029Phase 1Results posted
• The Summer Camp Study 2: Blood Glucose Control With a Bi-Hormonal Endocrine PancreasCompletedNCT02105324Not applicableResults posted
• The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 DiabetesCompletedNCT02098395Phase 3Results posted
• A Prospective, Randomized, Double-blind, Placebo Controlled Study to Assess the Impact of ORMD-0801 (Insulin Capsules) on the Exogenous Insulin Requirements of Type 1 DiabeticsCompletedNCT02094534Phase 2Results posted
• Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes MellitusTerminatedNCT02093221Phase 2Results posted
• A Multicenter Study of Outpatient Automated Blood Glucose Control With a Bihormonal Bionic PancreasCompletedNCT02092220Not applicableResults posted
• Patient and Provider Glucose Reporting Preferences Ambulatory Glucose Profile (AGP)CompletedNCT02074384Not applicableResults posted
• Effect of Gain on Closed-Loop InsulinCompletedNCT02065895Not applicableResults posted
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MK-1293 Compared With a Basal Insulin in Participants With Type 1 Diabetes (MK-1293-005)CompletedNCT02059174Phase 1Results posted
• A Study of the Safety and Efficacy of MK-1293 Compared to Lantus™ in Participants With Type 1 Diabetes Mellitus (T1DM) (MK-1293-003)CompletedNCT02059161Phase 3Results posted
• Advanced Bolus Calculator for Type 1 Diabetes (ABC4D)CompletedNCT02053051Not applicableResults posted
• Accelerometer Use in the Prevention of Exercise-Associated Hypoglycemia in Type 1 Diabetes: Outpatient Exercise ProtocolCompletedNCT02047643Not applicableResults posted
• Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes MellitusTerminatedNCT02044848Phase 2Results posted

← Diabetes Mellitus, Type 1 overview